Literature DB >> 2442187

Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma.

R C Baxter, C T Cowell.   

Abstract

An antibody raised against the major insulin-like growth factor (IGF)-binding protein in amniotic fluid (BP-28) was used to measure the levels of a cross-reacting protein in human plasma by RIA. Plasma BP-28 immunoreactivity had an apparent mol wt of 35,000 by high performance permeation chromatography. Sampled hourly for 12- or 24-h periods in 15 children with a wide range of GH secretory activity, plasma BP-28 levels showed a marked diurnal cycle, rising 10- to 20-fold between 2400 and 0600 h to a peak of 50-500 micrograms/L, then falling to basal levels (0-40 micrograms/L) by 1200 h. Plasma GH levels were measured at 20-min intervals in the same subjects. Neither peak nor basal BP-28 levels were significantly associated with chronological age, bone age, mean or peak nocturnal GH secretion, relative height, or relative growth velocity in tall, normal, short, or GH-deficient children. Plasma proteins measured in a RIA for 53,000 mol wt GH-dependent IGF-binding protein (BP-53) did not vary diurnally. The IGF-binding activity of plasma BP-28, measured by incubating plasma with IGF tracer and precipitating the BP-28-IGF complex with anti-BP-28 antiserum, closely paralleled the morning rise in BP-28 immunoreactivity. Immunoprecipitable BP-28 bound both IGF-I and IGF-II tracers, with a clear preference for IGF-I, and unlabeled IGF-I was more effective than IGF-II in displacing either tracer IGF. We conclude that plasma BP-28 levels in children have a marked diurnal rhythm which is unrelated to GH secretory activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442187     DOI: 10.1210/jcem-65-3-432

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

Review 1.  Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins.

Authors:  Iftekhar Mahmood; Martin D Green
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  The role of insulin, growth hormone and IGF-I as anabolic agents in the critically ill.

Authors:  R J Ross; J Rodriguez-Arnao; J Bentham; J H Coakley
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 3.  Somatomedin-binding proteins: what role do they play in the growth process?

Authors:  S Cianfarani; J M Holly
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

4.  The gene encoding human low-molecular weight insulin-like growth-factor binding protein (IGF-BP25): regional localization to 7p12-p13 and description of a DNA polymorphism.

Authors:  T Alitalo; K Kontula; R Koistinen; K Aalto-Setälä; M Julkunen; O A Jänne; M Seppälä; A de la Chapelle
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

5.  Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice.

Authors:  K Rajkumar; M Krsek; S T Dheen; L J Murphy
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

6.  Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus.

Authors:  K Brismar; M Gutniak; G Povoa; S Werner; K Hall
Journal:  J Endocrinol Invest       Date:  1988-09       Impact factor: 4.256

7.  Effect of glycemic control on growth hormone and IGFBP-1 secretion in patients with type I diabetes mellitus.

Authors:  L R Salgado; M Semer; M Nery; M Knoepfelmacher; A C Lerário; G Póvoa; S Jana; S M Villares; B L Wajchenberg; B Liberman; W Nicolau
Journal:  J Endocrinol Invest       Date:  1996 Jul-Aug       Impact factor: 4.256

Review 8.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

9.  Elevated plasma insulin-like growth factor binding protein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy.

Authors:  S R Crosby; C Tsigos; C D Anderton; C Gordon; R J Young; A White
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

10.  Insulin-like growth factor binding protein-3 protease activity in the urine of children with chronic renal failure.

Authors:  D Y Lee; P Cohen; A M Krensky; R G Rosenfeld; P D Yorgin
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.